Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHP in Catecholamine-Resistant Distributive Shock
DRKS00000181Phase 3Terminated
- Sponsor
- Apex Bioscience
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial in sepsis and Vasoplegia comparing PHP continuous infusion with Placebo continuous infusion (2 arms). Started Sep 2009; status: terminated.
02
Drugs
hemoximer
03
Conditions
sepsisVasoplegia
Beyond the preview
Go deeper on DRKS00000181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000181.